HCA
Receive regular headline summaries whenever high-quality news is generated for HCA. We'll never share your email address with others.
Selected Headlines
| Date | Headline (link) | Source | Relevant Snippet |
|---|---|---|---|
| 1/11/2022 | Re: Reston Hospital Center does not back vaccine mandate for staff | restonnow.com | ... care workers to get vaccinated.“While a majority of our staff are vaccinated, we continue to strongly encourage our colleagues to be vaccinated as a critical step to protect individuals from the virus,” HCA Healthcare’s communications director Suzanne Kelly told Reston Now.Kelly declined to release Reston Hospital Center’s vaccination rates and specific statistics about staff shortages at the Reston location.A majority of health systems in ... |
| 1/11/2022 | Candriam Luxembourg S.C.A. Sells 6,207 Shares of HCA Healthcare, Inc. (NYSE:HCA) | theenterpriseleader.com | Candriam Luxembourg S.C.A. cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.9% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 24,951 shares of the company’s stock after selling 6,207 shares during the period. Candriam Luxembourg S.C.A.’s holdings in HCA Healthcare were worth $6,056,000 at the end of the most recent quarter.Other hedge funds have also bought and sold shares of the company ... |
| 1/11/2022 | HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by BlackRock Inc. - American Banking News | American Banking News | BlackRock Inc. reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 4.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,063,941 shares of the company’s stock after selling 747,443 shares during the period. BlackRock Inc. owned 5.16% of HCA Healthcare worth $3,899,039,000 as of its most recent SEC filing.Other hedge funds also recently modified ... |
| 1/11/2022 | BlackRock Inc. Has $3.90 Billion Position in HCA Healthcare, Inc. (NYSE:HCA) | theenterpriseleader.com | BlackRock Inc. reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,063,941 shares of the company’s stock after selling 747,443 shares during the period. BlackRock Inc. owned 0.05% of HCA Healthcare worth $3,899,039,000 at the end of the most recent reporting period.Other hedge funds have also modified ... |
| 1/11/2022 | Beacon Investment Advisory Services Inc. Purchases New Holdings in HCA Healthcare, Inc. (NYSE:HCA) - Stock Observer | thestockobserver.com | Beacon Investment Advisory Services Inc. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 12,077 shares of the company’s stock, valued at approximately $2,931,000.A number of other large investors have also added to or reduced their stakes in HCA. Itau Unibanco Holding S.A. bought ... |
| 1/11/2022 | HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Cut by Catalyst Capital Advisors LLC - WKRB News | wkrb13.com | Catalyst Capital Advisors LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 30.7% in the third quarter, HoldingsChannel.com reports. The firm owned 9,887 shares of the company’s stock after selling 4,373 shares during the period. Catalyst Capital Advisors LLC’s holdings in HCA Healthcare were worth $2,400,000 at the end of the most recent reporting period.Other hedge funds and other institutional investors have also ... |
| 1/11/2022 | SVB Leerink Comments on HCA Healthcare, Inc.'s Q1 2022 Earnings (NYSE:HCA) - Stock Observer | thestockobserver.com | HCA Healthcare, Inc. (NYSE:HCA) – Equities research analysts at SVB Leerink cut their Q1 2022 EPS estimates for shares of HCA Healthcare in a report released on Thursday, January 6th. SVB Leerink analyst W. Mayo now forecasts that the company will post earnings of $4.63 per share for the quarter, down from their previous estimate of $4.68. SVB Leerink currently has a “Outperform” rating and a $320.00 target ... |
| 1/11/2022 | HCA Healthcare, Inc. Expected to Post Q1 2022 Earnings of $4.63 Per Share (NYSE:HCA) | The Markets Daily | HCA Healthcare, Inc. (NYSE:HCA) – Equities researchers at SVB Leerink cut their Q1 2022 earnings per share (EPS) estimates for HCA Healthcare in a research note issued to investors on Thursday, January 6th. SVB Leerink analyst W. Mayo now forecasts that the company will earn $4.63 per share for the quarter, down from their previous forecast of $4.68. SVB Leerink has a “Outperform” rating and a $320.00 price ... |
| 1/10/2022 | SVB Leerink Weighs in on HCA Healthcare, Inc.'s Q1 2022 Earnings (NYSE:HCA) | etfdailynews.com | HCA Healthcare, Inc. (NYSE:HCA) – Equities researchers at SVB Leerink reduced their Q1 2022 EPS estimates for HCA Healthcare in a research report issued on Thursday, January 6th. SVB Leerink analyst W. Mayo now forecasts that the company will earn $4.63 per share for the quarter, down from their previous forecast of $4.68. SVB Leerink has a “Outperform” rating and a $320.00 price target on the stock. SVB ... |
| 1/10/2022 | HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Inspire Investing LLC | Daily Political | HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Inspire Investing LLC Posted by Patrick Bannon on Jan 10th, 2022 Share on StocktwitsInspire Investing LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1,521.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,355 shares of the company’s stock after acquiring an additional ... |
| 1/10/2022 | Moors & Cabot Inc. Takes Position in HCA Healthcare, Inc. (NYSE:HCA) - Slater Sentinel | slatersentinel.com | Moors & Cabot Inc. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 8,262 shares of the company’s stock, valued at approximately $211,000.Several other institutional investors have also recently bought and sold shares of the company. Boston Partners lifted its holdings in shares of HCA Healthcare by ... |
| 1/10/2022 | BioSig to Present at the 27th Annual International AF Symposium | hmpgloballearningnetwork.com | PURE EP™ System to be highlighted in a Spotlight Session by DJ Lakkireddy, M.D., Kansas City Heart Rhythm Institute at HCA Midwest HealthWestport, CT, Jan. 07, 2022 – BioSig Technologies, Inc., a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced that the Company would be presenting at the 27th Annual ... |
| 1/9/2022 | HCA Healthcare, Inc. to Post FY2021 Earnings of $17.69 Per Share, Jefferies Financial Group Forecasts (NYSE:HCA) | The Markets Daily | HCA Healthcare, Inc. (NYSE:HCA) – Equities researchers at Jefferies Financial Group issued their FY2021 earnings per share (EPS) estimates for HCA Healthcare in a research note issued to investors on Tuesday, January 4th. Jefferies Financial Group analyst B. Tanquilut forecasts that the company will earn $17.69 per share for the year. Jefferies Financial Group also issued estimates for HCA Healthcare’s Q4 2021 earnings at $4.61 EPS.HCA Healthcare ... |
| 1/9/2022 | HCA Healthcare, Inc. to Post FY2021 Earnings of $17.69 Per Share, Jefferies Financial Group Forecasts (NYSE:HCA) | Dakota Financial News | HCA Healthcare, Inc. (NYSE:HCA) – Research analysts at Jefferies Financial Group issued their FY2021 earnings per share (EPS) estimates for HCA Healthcare in a research note issued to investors on Tuesday, January 4th. Jefferies Financial Group analyst B. Tanquilut expects that the company will earn $17.69 per share for the year. Jefferies Financial Group also issued estimates for HCA Healthcare’s Q4 2021 earnings at $4.61 EPS.A number ... |
| 1/9/2022 | qPULA Trading Management LP Takes $437,000 Position in HCA Healthcare, Inc. (NYSE:HCA) - Dakota Financial News | Dakota Financial News | qPULA Trading Management LP acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,800 shares of the company’s stock, valued at approximately $437,000.Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. FMR LLC boosted its holdings ... |
| 1/7/2022 | BioSig to Present at the 27th Annual International AF | Globe Newswire | ... the 27th Annual International Atrial Fibrillation Symposium on January 13-15, 2022.Clinical observations collected with BioSig’s PURE EP™ System will be presented by DJ Lakkireddy, M.D., Kansas City Heart Rhythm Institute at HCA Midwest Health during Spotlight Session : Complex AF Case Study Utilizing a New Standard in Signal Processing on January 13, 2022, from 8:30-9:30 AM ET.“Dr. Lakkireddy is highly regarded for his passionate commitment to those ... |
| 1/7/2022 | BioSig to Present at the 27th Annual International AF Symposium | Yahoo News | PURE EP (TM) System to be highlighted in a Spotlight Session by DJ Lakkireddy, M.D., Kansas City Heart Rhythm Institute at HCA Midwest HealthWestport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced ... |
| 1/7/2022 | BioSig to Present at the 27th Annual International AF Symposium | 2022-01-07 | Press Releases | Stockhouse | stockhouse.com | BSGM 19 hours ago PURE EP (TM) System to be highlighted in a Spotlight Session by DJ Lakkireddy, M.D., Kansas City Heart Rhythm Institute at HCA Midwest Health Westport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig&CloseCurlyDoubleQuote: ; or the “Company&CloseCurlyDoubleQuote: ;), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra ... |
| 1/7/2022 | BioSig to Present at the 27th Annual International AF Symposium | forextv.com | PURE EP (TM) System to be highlighted in a Spotlight Session by DJ Lakkireddy, M.D., Kansas City Heart Rhythm Institute at HCA Midwest HealthWestport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today ... |
| 1/7/2022 | BioSig to Present at the 27th Annual International AF Symposium | News | bakersfield.com | bakersfield.com | ... the 27th Annual International Atrial Fibrillation Symposium on January 13-15, 2022.Clinical observations collected with BioSig’s PURE EP™ System will be presented by DJ Lakkireddy, M.D., Kansas City Heart Rhythm Institute at HCA Midwest Health during Spotlight Session: Complex AF Case Study Utilizing a New Standard in Signal Processing on January 13, 2022, from 8:30-9:30 AM ET.“Dr. Lakkireddy is highly regarded for his passionate commitment to those ... |